Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 1;12(2):344.
doi: 10.3390/antiox12020344.

Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage

Affiliations

Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage

Elisabetta Marini et al. Antioxidants (Basel). .

Abstract

In the last years, research proofs have confirmed that hydrogen sulfide (H2S) plays an important role in various physio-pathological processes, such as oxidation, inflammation, neurophysiology, and cardiovascular protection; in particular, the protective effects of H2S in cardiovascular diseases were demonstrated. The interest in H2S-donating molecules as tools for biological and pharmacological studies has grown, together with the understanding of H2S importance. Here we performed a comparative study of a series of H2S donor molecules with different chemical scaffolds and H2S release mechanisms. The compounds were tested in human serum for their stability and ability to generate H2S. Their vasorelaxant properties were studied on rat aorta strips, and the capacity of the selected compounds to protect NO-dependent endothelium reactivity in an acute oxidative stress model was tested. H2S donors showed different H2S-releasing kinetic and produced amounts and vasodilating profiles; in particular, compound 6 was able to attenuate the dysfunction of relaxation induced by pyrogallol exposure, showing endothelial protective effects. These results may represent a useful basis for the rational development of promising H2S-releasing agents also conjugated with other pharmacophores.

Keywords: hydrogen sulfide; hydrogen sulfide-donors; oxidative stress; pyrogallol; superoxide anion; vascular endothelium; vasodilation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Structures of H2S donor molecules.
Figure 2
Figure 2
Vasodilating effects on rat aorta strips precontracted with 25 mM KCl: (a) 6 (dotted line, ●), 6 and 10 μM glibenclamide (straight line, ○); (b) 8 (dotted line, ■), 8 and 10 μM glibenclamide (straight line, □).
Figure 3
Figure 3
Effect of 6 (100 μM) on acetylcholine-induced vasodilation in endothelium-intact rat aortic rings. Control: rings incubated with vehicle only (DMSO) (straight line, □); rings incubated with 6 (straight line, ○); rings incubated with 500 μM pyrogallol (straight line, ■); rings incubated with 6 and 500 μM pyrogallol (straight line, ●); rings incubated with catechin (10 mM) and 500 μM pyrogallol (dotted line, ∆). Statistical analyses were made using Student’s t-test for unpaired data. ** p < 0.01 vs. the pyrogallol group.

Similar articles

Cited by

References

    1. Wang R. Hydrogen sulfide: The third gasotransmitter in biology and medicine. Antioxid. Redox Signal. 2010;12:1061–1064. doi: 10.1089/ars.2009.2938. - DOI - PubMed
    1. Wang R. Two’s company, three’s a crowd: Can H2S be the third endogenous gaseous transmitter. FASEB J. 2002;16:1792–1798. doi: 10.1096/fj.02-0211hyp. - DOI - PubMed
    1. Abe K., Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci. 1996;16:1066–1071. doi: 10.1523/JNEUROSCI.16-03-01066.1996. - DOI - PMC - PubMed
    1. Szabo C. Gasotransmitters in cancer: From pathophysiology to experimental therapy. Nat. Rev. Drug Discov. 2016;15:185–203. doi: 10.1038/nrd.2015.1. - DOI - PMC - PubMed
    1. Szabo C. A timeline of hydrogen sulfide (H2S) research: From environmental toxin to biological mediator. Biochem. Pharmacol. 2018;149:5–19. doi: 10.1016/j.bcp.2017.09.010. - DOI - PMC - PubMed